Initiator Pharma A/S: Financial statements 2024
CVR: 37663808
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Initiator Pharma A/S (CVR 37663808) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -11,073,000 and a net result of DKK -12,932,000 compared with DKK -22,873,000 the year before. Equity in the 2024 report amounted to DKK 14,782,000. The solvency ratio was 93.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -11,073,000
- Profit/Loss
- DKK -12,932,000
- Equity
- DKK 14,782,000
- Total Assets
- DKK 15,835,000
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -11.1M | -12.9M | 14.8M | 2 |
| 2023 | - | -23.4M | -22.9M | 11.2M | 2 |
| 2022 | - | -38.4M | -38.5M | 34M | 3 |
| 2021 | - | -22K | -21K | 35K | - |
| 2020 | - | -9.3M | -8.7M | 14.4M | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Initiator Pharma A/S has published its annual report for 2023. Gross profit came to DKK -23,413,000, and the net result was DKK -22,873,000.
About Initiator Pharma A/S
Initiator Pharma A/S is a Danish company of the type Aktieselskab based in København N, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Elsborg Olesen. The board consists of Gunnar Magnus Severus Modée Persson (chair), Annette Ingegerd Marie Colin, Claus Elsborg Olesen and Majken Christina Östberg Lloyd. The company is owned by Linc AB and Adrigo Asset Management. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000.
